Reduced GAD65/67 immunoreactivity in the hypothalamic paraventricular nucleus in depression: A postmortem study

Background aminobutyric acid (GABA) is a major inhibitory neurotransmitter. It diminishes the activity of the hypothalamo–pituitary–adrenal (HPA) axis, which plays an important role in the pathogenesis of depression. The present study aimed at determining GABAergic input in the hypothalamic paraventricular nucleus (PVN) in depression and its correlation with the activity of corticotropin-releasing hormone (CRH) neurons. s nsity of glutamic acid decarboxylase (GAD)65/67-immunoreactivity (ir) was quantified in the postmortem hypothalamic PVN of 9 major depressive (MDD) and 5 bipolar depressive (BD) patients, together with 12 matched controls, whose CRH-expressing neuron numbers had been determined in a previous study. s was a 43% significant reduction of the density of GAD65/67-ir in the PVN in MDD (P=0.028) and a 20% non-significant decrease in BD patients. In addition, there was a significant negative correlation between the density of GAD65/67-ir and the number of CRH-ir neurons in the PVN in the depression group (Rho=−0.527, P=0.032), but not in the control group. tions mples were relatively small and the depression group had used antidepressants. sion nished GABAergic input to the PVN may contribute to the activation of CRH-ir neurons in depression, most prominently in MDD, which provides a rationale for prescribing GABAergic agonists for these patients.